AAAAAA

   
Results: 1-8 |
Results: 8
Synthesis and biological activity of novel epothilone aziridines
Authors: Regueiro-Ren, A Borzilleri, RM Zheng, XP Kim, SH Johnson, JA Fairchild, CR Lee, FYF Long, BH Vite, GD
Citation: A. Regueiro-ren et al., Synthesis and biological activity of novel epothilone aziridines, ORG LETT, 3(17), 2001, pp. 2693-2696
Preclinical pharmacology of BMS-275183, an orally active taxane
Authors: Rose, WC Long, BH Fairchild, CR Lee, FYF Kadow, JF
Citation: Wc. Rose et al., Preclinical pharmacology of BMS-275183, an orally active taxane, CLIN CANC R, 7(7), 2001, pp. 2016-2021
BMS-247550: A novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy
Authors: Lee, FYF Borzilleri, R Fairchild, CR Kim, SH Long, BH Reventos-Suarez, C Vite, GD Rose, WC Kramer, RA
Citation: Fyf. Lee et al., BMS-247550: A novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy, CLIN CANC R, 7(5), 2001, pp. 1429-1437
Preclinical antitumor activity of two novel taxanes
Authors: Rose, WC Fairchild, C Lee, FYF
Citation: Wc. Rose et al., Preclinical antitumor activity of two novel taxanes, CANC CHEMOT, 47(2), 2001, pp. 97-105
Preclinical antitumor activity of BMS-214662, a highly apoptotic and novelfarnesyltransferase inhibitor
Authors: Rose, WC Lee, FYF Fairchild, CR Lynch, M Monticello, T Kramer, RA Manne, V
Citation: Wc. Rose et al., Preclinical antitumor activity of BMS-214662, a highly apoptotic and novelfarnesyltransferase inhibitor, CANCER RES, 61(20), 2001, pp. 7507-7517
Preclinical oral antitumor activity of BMS-185660, a paclitaxel derivative
Authors: Rose, WC Lee, FYF Golik, J Kadow, J
Citation: Wc. Rose et al., Preclinical oral antitumor activity of BMS-185660, a paclitaxel derivative, CANC CHEMOT, 46(3), 2000, pp. 246-250
Discovery of (R)-7-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity
Authors: Hunt, JT Ding, CZ Batorsky, R Bednarz, M Bhide, R Cho, Y Chong, S Chao, S Gullo-Brown, J Guo, P Kim, SH Lee, FYF Leftheris, K Miller, A Mitt, T Patel, M Penhallow, BA Ricca, C Rose, WC Schmidt, R Slusarchyk, WA Vite, G Manne, V
Citation: Jt. Hunt et al., Discovery of (R)-7-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity, J MED CHEM, 43(20), 2000, pp. 3587-3595
A novel application of a Pd(0)-catalyzed nucleophilic substitution reaction to the regio- and stereoselective synthesis of lactam analogues of the epothilone natural products
Authors: Borzilleri, RM Zheng, XP Schmidt, RJ Johnson, JA Kim, SH DiMarco, JD Fairchild, CR Gougoutas, JZ Lee, FYF Long, BH Vite, GD
Citation: Rm. Borzilleri et al., A novel application of a Pd(0)-catalyzed nucleophilic substitution reaction to the regio- and stereoselective synthesis of lactam analogues of the epothilone natural products, J AM CHEM S, 122(37), 2000, pp. 8890-8897
Risultati: 1-8 |